Scarica l'app Stockscreener
5.56
9.92%
0.502
Precedente Chiudi:
$5.058
Aprire:
$5.11
Volume 24 ore:
180.78K
Relative Volume:
0.27
Capitalizzazione di mercato:
$11.29M
Reddito:
$7.11M
Utile/perdita netta:
$-41.28M
Rapporto P/E:
-4.029
EPS:
-1.38
Flusso di cassa netto:
$-26.84M
1 W Prestazione:
-21.13%
1M Prestazione:
-47.05%
6M Prestazione:
-35.20%
1 anno Prestazione:
-74.35%
Intervallo 1D:
$4.84
$5.79
Intervallo di 1 settimana:
$4.84
$7.191
Portata 52W:
$4.84
$46.50
Co Diagnostics Inc Stock (CODX) Company Profile
Nome
Co Diagnostics Inc
Settore
Industria
Telefono
(801) 278-9769
Indirizzo
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Confronta CODX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
5.56 | 342.22K | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
124.19 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
94.71 | 141.35B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
348.18 | 134.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.05 | 123.15B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.33 | 49.47B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-12 | Downgrade | Sidoti | Buy → Neutral |
| 2021-12-29 | Iniziato | Sidoti | Buy |
| 2021-03-29 | Downgrade | Maxim Group | Buy → Hold |
| 2020-05-20 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention and Expo on Oct 2-3 - marketscreener.com
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Finviz
Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - The Globe and Mail
Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance
Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn
Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus
Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - marketscreener.com
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com South Africa
Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com India
Biotech Co-Diagnostics shrinks share count 30-to-1 to stay on Nasdaq - Stock Titan
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - The Malaysian Reserve
Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus
Co-diagnostics receives Australian patent for PCR testing platform By Investing.com - Investing.com India
Co-diagnostics receives Australian patent for PCR testing platform - Investing.com Australia
New point-of-care PCR tech for flu and COVID secures patent in Australia - Stock Titan
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Aug Breakouts: How resilient is Co Diagnostics Inc. stock in market downturns - Улправда
Can Co Diagnostics Inc. stock sustain market leadershipWeekly Trade Report & Low Drawdown Momentum Trade Ideas - Улправда
Why Co Diagnostics Inc. stock is seen as undervaluedJuly 2025 Update & Stepwise Trade Signal Guides - Улправда
Will Co Diagnostics Inc. stock deliver consistent dividends2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - DonanımHaber
Can Co Diagnostics Inc. stock weather global recession2025 Trading Volume Trends & Reliable Price Breakout Signals - ulpravda.ru
Bond Watch: Is Co Diagnostics Inc. stock a buy in volatile markets2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - DonanımHaber
How resilient is Co Diagnostics Inc. stock in market downturnsPortfolio Risk Summary & AI Forecast Swing Trade Picks - Улправда
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in - GuruFocus
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India - Barchart.com
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Con - GuruFocus
Co-Diagnostics (CODX) Validates Efficacy of Influenza and COVID-19 Detection Test - GuruFocus
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation - Nasdaq
Co Diagnostics Inc Stock Analysis and ForecastRisk Mitigation Techniques & Affordable Trading Techniques - earlytimes.in
Certain Warrants of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Certain Stock Options of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
48,142,582 Common Stock of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Value Recap: Will Co Diagnostics Inc stock deliver consistent dividendsMarket Growth Summary & High Accuracy Swing Entry Alerts - moha.gov.vn
Co-Diagnostics, Arabian Eagle to Develop and Commercialize Co-Dx Tech - Medical Product Outsourcing
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN
CapEx per share of Co-Diagnostics, Inc. – MUN:C97 - TradingView — Track All Markets
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025 - Barchart.com
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pun - GuruFocus
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India - Sahm
Co-Diagnostics (Nasdaq: CODX) JV highlights TB, HPV PoC tests at VIROCON 2025 - Stock Titan
Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN
Co-Diagnostics Approves Reverse Stock Split Proposal - The Globe and Mail
Co-Diagnostics approves reverse stock split proposal - MSN
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - MSN
Co Diagnostics Inc Azioni (CODX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.46%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):